XML 19 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Capital In Excess of Par Value
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2018     198,595            
Beginning balance at Dec. 31, 2018 $ 10,161   $ 33 $ 2,535 $ 15,072   $ (159) $ (7,320) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 2,707       2,707        
Other comprehensive income (loss) 315       0   315    
Common stock repurchases (1,070)     150       (1,220)  
Dividends and dividend equivalents (296)       (296)        
Stock-based compensation 163     163          
Restricted stock unit vesting (in shares)     32            
Restricted stock unit vesting 0     (48)       48  
Stock option exercises (in shares)     3            
Stock option exercises 57     20       37  
Ending balance (in shares) at Dec. 31, 2019     198,630            
Ending balance at Dec. 31, 2019 12,037 $ (2) $ 33 2,820 17,483 $ (2) 156 (8,455) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 3,367       3,367        
Other comprehensive income (loss) 235       0   235    
Common stock repurchases (1,820)     (263)       (1,557)  
Dividends and dividend equivalents (331)       (331)        
Stock-based compensation 181     181          
Restricted stock unit vesting (in shares)     19            
Restricted stock unit vesting 0     (59)       59  
Stock option exercises (in shares)     0            
Stock option exercises 61     26       35  
Ending balance (in shares) at Dec. 31, 2020     198,649            
Ending balance at Dec. 31, 2020 13,728   $ 33 2,705 20,517   391 (9,918) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 2,934       2,933       1
Acquisition 22               22
Other comprehensive income (loss) (349)           (349)    
Common stock repurchases (79)     262       (341)  
Dividends and dividend equivalents (364)       (364)        
Stock-based compensation 180     180          
Restricted stock unit vesting 0     (81)       81  
Stock option exercises 31     16       15  
Ending balance (in shares) at Dec. 31, 2021     198,649            
Ending balance at Dec. 31, 2021 $ 16,103   $ 33 $ 3,082 $ 23,086   $ 42 $ (10,163) $ 23